Fig. 1From: Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascitesA 5-years Kaplan–Meier survival analysis comparing subjects with malignant ascites with and without liver metastasis demonstrating higher mortality rates in those with liver metastasis. B 5-years Kaplan–Meier survival analysis comparing subjects with peritoneal carcinomatosis on cytology and or imaging to subjects without evidence of PC. C 3-years Kaplan–Meier survival analysis comparing subjects with peritoneal carcinomatosis on cytology and or imaging to subjects without evidence of PC. D 1-years Kaplan–Meier survival analysis comparing subjects with peritoneal carcinomatosis on cytology and or imaging to subjects without evidence of PC. E 5-years Kaplan–Meier survival analysis comparing subjects with pancreatic cancer and peritoneal carcinomatosis on cytology and or imaging to subjects without evidence of PC. F 1-years Kaplan–Meier survival analysis comparing subjects with pancreatic cancer and peritoneal carcinomatosis on cytology and or imaging to subjects without evidence of PCBack to article page